{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T10:35:16Z","timestamp":1787567716596,"version":"build-2736575974"},"reference-count":50,"publisher":"eLife Sciences Publications, Ltd","license":[{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["19187977"],"award-info":[{"award-number":["19187977"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22H02875"],"award-info":[{"award-number":["22H02875"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["20333128"],"award-info":[{"award-number":["20333128"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["22723616"],"award-info":[{"award-number":["22723616"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elifesciences.org"],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Intranasal vaccination is an attractive strategy for preventing COVID-19 disease as it stimulates the production of multimeric secretory immunoglobulin A (IgA), the predominant antibody isotype in the mucosal immune system, at the target site of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) entry. Currently, intranasal vaccine efficacy is evaluated based on the measurement of polyclonal antibody titers in nasal lavage fluid. However, how individual multimeric secretory IgA protects the mucosa from SARS-CoV-2 infection remains to be elucidated. To understand the precise contribution and molecular nature of multimeric secretory IgA induced by intranasal vaccines, we developed 99 monoclonal IgA clones from nasal mucosa and 114 monoclonal IgA or IgG clones from nonmucosal tissues of mice that were intranasally immunized with the SARS-CoV-2 spike protein. The nonmucosal IgA clones exhibited shared origins and common and unique somatic mutations with the related nasal IgA clones, indicating that the antigen-specific plasma cells in the nonmucosal tissues originated from B cells stimulated at the nasal mucosa. Comparing the spike protein binding reactivity, angiotensin-converting enzyme-2-blocking, and in vitro SARS-CoV-2 virus neutralization of monomeric and multimeric secretory IgA pairs recognizing different epitopes showed that even non-neutralizing monomeric IgAs, which represent 70% of the nasal IgA repertoire, can protect against SARS-CoV-2 infection when expressed as multimeric secretory IgAs. We also demonstrated that the intranasal administration of multimeric secretory IgA delivered as prophylaxis in the hamster model reduced infection-induced weight loss. Our investigation is the first to demonstrate the function of nasal IgA at the monoclonal level, showing that nasal immunization can provide effective immunity against SARS-CoV-2 by inducing multimeric secretory IgAs at the target site of the virus infection.<\/jats:p>","DOI":"10.7554\/elife.88387","type":"journal-article","created":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T06:21:00Z","timestamp":1699338060000},"update-policy":"https:\/\/doi.org\/10.7554\/elife.88387","source":"Crossref","is-referenced-by-count":6,"title":["Comprehensive analysis of nasal IgA antibodies induced by intranasal administration of the SARS-CoV-2 spike protein"],"prefix":"10.7554","volume":"12","author":[{"given":"Kentarou","family":"Waki","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0445phv87","id-type":"ROR","asserted-by":"publisher"}],"name":"Laboratory of Molecular and Cellular Biology, Graduate School of Science and Engineering for Education, University of Toyama","place":["Toyama, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6309-277X","authenticated-orcid":true,"given":"Hideki","family":"Tani","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00a3bx267","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Virology, Toyama Institute of Health","place":["Toyama, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Eigo","family":"Kawahara","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0445phv87","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Microbiology, Toyama University Graduate School of Medicine and Pharmaceutical Sciences","place":["Toyama, Japan"]},{"id":[{"id":"https:\/\/ror.org\/0445phv87","id-type":"ROR","asserted-by":"publisher"}],"name":"Center for Advanced Antibody Drug Development, University of Toyama","place":["Toyama, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Yumiko","family":"Saga","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00a3bx267","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Virology, Toyama Institute of Health","place":["Toyama, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"formal-analysis","vocabulary":"credit"}]},{"given":"Takahisa","family":"Shimada","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00a3bx267","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Virology, Toyama Institute of Health","place":["Toyama, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"formal-analysis","vocabulary":"credit"}]},{"given":"Emiko","family":"Yamazaki","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00a3bx267","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Virology, Toyama Institute of Health","place":["Toyama, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"formal-analysis","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8203-4498","authenticated-orcid":true,"given":"Seiichi","family":"Koike","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0445phv87","id-type":"ROR","asserted-by":"publisher"}],"name":"Laboratory of Molecular and Cellular Biology, Graduate School of Innovative Life Science, University of Toyama","place":["Toyama, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Yoshitomo","family":"Morinaga","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0445phv87","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Microbiology, Toyama University Graduate School of Medicine and Pharmaceutical Sciences","place":["Toyama, Japan"]},{"id":[{"id":"https:\/\/ror.org\/0445phv87","id-type":"ROR","asserted-by":"publisher"}],"name":"Center for Advanced Antibody Drug Development, University of Toyama","place":["Toyama, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Masaharu","family":"Isobe","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0445phv87","id-type":"ROR","asserted-by":"publisher"}],"name":"Center for Advanced Antibody Drug Development, University of Toyama","place":["Toyama, Japan"]},{"id":[{"id":"https:\/\/ror.org\/0445phv87","id-type":"ROR","asserted-by":"publisher"}],"name":"Laboratory of Molecular and Cellular Biology, Graduate School of Innovative Life Science, University of Toyama","place":["Toyama, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1548-4541","authenticated-orcid":true,"given":"Nobuyuki","family":"Kurosawa","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0445phv87","id-type":"ROR","asserted-by":"publisher"}],"name":"Center for Advanced Antibody Drug Development, University of Toyama","place":["Toyama, Japan"]},{"id":[{"id":"https:\/\/ror.org\/0445phv87","id-type":"ROR","asserted-by":"publisher"}],"name":"Laboratory of Molecular and Cellular Biology, Graduate School of Innovative Life Science, University of Toyama","place":["Toyama, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"},{"role":"data-curation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]}],"member":"4374","published-online":{"date-parts":[[2025,5,8]]},"reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.cell.2022.02.005","type":"journal-article","article-title":"Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2","volume":"185","author":"Afkhami","year":"2022","journal-title":"Cell"},{"key":"bib2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.103841","type":"journal-article","article-title":"Intranasal COVID-19 vaccines: from bench to bed","volume":"76","author":"Alu","year":"2022","journal-title":"EBioMedicine"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.4049\/jimmunol.168.6.2930","type":"journal-article","article-title":"Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines","volume":"168","author":"Asahi","year":"2002","journal-title":"Journal of Immunology"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/jmv.20173","type":"journal-article","article-title":"Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus","volume":"74","author":"Asahi-Ozaki","year":"2004","journal-title":"Journal of Medical Virology"},{"key":"bib5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103788","type":"journal-article","article-title":"Mucosal immune response in BNT162b2 COVID-19 vaccine recipients","volume":"75","author":"Azzi","year":"2022","journal-title":"EBioMedicine"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41591-020-01179-4","type":"journal-article","article-title":"Phase 1\/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses","volume":"27","author":"Barrett","year":"2021","journal-title":"Nature Medicine"},{"key":"bib7","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109400","type":"journal-article","article-title":"A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters","volume":"36","author":"Bricker","year":"2021","journal-title":"Cell Reports"},{"key":"bib8","doi-asserted-by":"publisher","DOI":"10.1172\/JCI149412","type":"journal-article","article-title":"Distinctive features of severe SARS-CoV-2 pneumonia","volume":"131","author":"Budinger","year":"2021","journal-title":"The Journal of Clinical Investigation"},{"key":"bib9","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202153956","type":"journal-article","article-title":"Potent neutralization by monoclonal human IgM against SARS-CoV-2 is impaired by class switch","volume":"23","author":"Callegari","year":"2022","journal-title":"EMBO Reports"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1016\/j.drudis.2021.07.021","type":"journal-article","article-title":"Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management","volume":"26","author":"Chavda","year":"2021","journal-title":"Drug Discovery Today"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.vaccine.2021.01.040","type":"journal-article","article-title":"Single-dose intranasal subunit vaccine rapidly clears secondary sepsis in a high-dose pneumonic plague infection","volume":"39","author":"D\u2019Arco","year":"2021","journal-title":"Vaccine"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1038\/s41587-020-0732-8","type":"journal-article","article-title":"COVID-19 antibodies on trial","volume":"38","author":"DeFrancesco","year":"2020","journal-title":"Nature Biotechnology"},{"key":"bib13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00934","type":"journal-article","article-title":"Mucosal immunity and protective efficacy of intranasal inactivated influenza vaccine is improved by chitosan nanoparticle delivery in pigs","volume":"9","author":"Dhakal","year":"2018","journal-title":"Frontiers in Immunology"},{"key":"bib14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18058-8","type":"journal-article","article-title":"A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction","volume":"11","author":"Ejemel","year":"2020","journal-title":"Nature Communications"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-020-01194-5","type":"journal-article","article-title":"T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1\/2 clinical trial","volume":"27","author":"Ewer","year":"2021","journal-title":"Nature Medicine"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cell.2015.01.016","type":"journal-article","article-title":"Intra-spike crosslinking overcomes antibody evasion by HIV-1","volume":"160","author":"Galimidi","year":"2015","journal-title":"Cell"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/irv.12664","type":"journal-article","article-title":"How to assess the effectiveness of nasal influenza vaccines? Role and measurement of sIgA in mucosal secretions","volume":"13","author":"Gianchecchi","year":"2019","journal-title":"Influenza and Other Respiratory Viruses"},{"key":"bib18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009542","type":"journal-article","article-title":"Nasal delivery of single-domain antibody improves symptoms of SARS-CoV-2 infection in an animal model","volume":"17","author":"Haga","year":"2021","journal-title":"PLOS Pathogens"},{"key":"bib19","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-022-01405-w","type":"journal-article","article-title":"SARS-CoV-2 mucosal vaccine","volume":"24","author":"Houston","year":"2023","journal-title":"Nature Immunology"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","type":"journal-article","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nature Reviews. Molecular Cell Biology"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1002\/eji.202149167","type":"journal-article","article-title":"A single subcutaneous or intranasal immunization with adenovirus-based SARS-CoV-2 vaccine induces robust humoral and cellular immune responses in mice","volume":"51","author":"Kim","year":"2021","journal-title":"European Journal of Immunology"},{"key":"bib22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000908","type":"journal-article","article-title":"Few and far between: how HIV may be evading antibody avidity","volume":"6","author":"Klein","year":"2010","journal-title":"PLOS Pathogens"},{"key":"bib23","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6750-11-39","type":"journal-article","article-title":"Target-selective homologous recombination cloning for high-throughput generation of monoclonal antibodies from single plasma cells","volume":"11","author":"Kurosawa","year":"2011","journal-title":"BMC Biotechnology"},{"key":"bib24","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7007-10-80","type":"journal-article","article-title":"Rapid production of antigen-specific monoclonal antibodies from a variety of animals","volume":"10","author":"Kurosawa","year":"2012","journal-title":"BMC Biology"},{"key":"bib25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27063-4","type":"journal-article","article-title":"Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization","volume":"12","author":"Lapuente","year":"2021","journal-title":"Nature Communications"},{"key":"bib26","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2032057","type":"journal-article","article-title":"The effects of secretory IgA in the mucosal immune system","volume":"2020","author":"Li","year":"2020","journal-title":"BioMed Research International"},{"key":"bib27","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11010030","type":"journal-article","article-title":"Characterization of systemic and mucosal humoral immune responses to an adjuvanted intranasal SARS-CoV-2 protein subunit vaccine candidate in mice","volume":"11","author":"Maltseva","year":"2022","journal-title":"Vaccines"},{"key":"bib28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2315354120","type":"journal-article","article-title":"Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents infection of Omicron lineages","volume":"121","author":"Marcotte","year":"2024","journal-title":"PNAS"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1146\/annurev-immunol-101320-123742","type":"journal-article","article-title":"Molecular mechanisms of multimeric assembly of IgM and IgA","volume":"40","author":"Matsumoto","year":"2022","journal-title":"Annual Review of Immunology"},{"key":"bib30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085582","type":"journal-article","article-title":"Comparison of antiviral activity between IgA and IgG specific to influenza virus hemagglutinin: increased potential of IgA for heterosubtypic immunity","volume":"9","author":"Muramatsu","year":"2014","journal-title":"PLOS ONE"},{"key":"bib31","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103379","type":"journal-article","article-title":"Non-propagative human parainfluenza virus type 2 nasal vaccine robustly protects the upper and lower airways against SARS-CoV-2","volume":"24","author":"Ohtsuka","year":"2021","journal-title":"iScience"},{"key":"bib32","doi-asserted-by":"publisher","DOI":"10.3390\/v12070780","type":"journal-article","article-title":"Comparative analyses of the antiviral activities of IgG and IgA antibodies to influenza a virus M2 protein","volume":"12","author":"Okuya","year":"2020","journal-title":"Viruses"},{"key":"bib33","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00408-20","type":"journal-article","article-title":"Potential role of nonneutralizing iga antibodies in cross-protective immunity against influenza a viruses of multiple hemagglutinin subtypes","volume":"94","author":"Okuya","year":"2020","journal-title":"Journal of Virology"},{"key":"bib34","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2022.2072455","type":"journal-article","article-title":"Novel super-neutralizing antibody UT28K is capable of protecting against infection from a wide variety of SARS-CoV-2 variants","volume":"14","author":"Ozawa","year":"2022","journal-title":"mAbs"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","type":"journal-article","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"The New England Journal of Medicine"},{"key":"bib36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007427","type":"journal-article","article-title":"IgA tetramerization improves target breadth but not peak potency of functionality of anti-influenza virus broadly neutralizing antibody","volume":"15","author":"Saito","year":"2019","journal-title":"PLOS Pathogens"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41385-022-00511-0","type":"journal-article","article-title":"Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection","volume":"15","author":"Sheikh-Mohamed","year":"2022","journal-title":"Mucosal Immunology"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1084\/jem.194.11.1597","type":"journal-article","article-title":"Isotype-specific selection of high affinity memory B cells in nasal-associated lymphoid tissue","volume":"194","author":"Shimoda","year":"2001","journal-title":"The Journal of Experimental Medicine"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1051\/medsci\/2021154","type":"journal-article","article-title":"IgA dominates the early neutralizing antibody response to SARS-CoV-2 virus","volume":"37","author":"Sterlin","year":"2021","journal-title":"M S-Medecine Sciences"},{"key":"bib40","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.148494","type":"journal-article","article-title":"Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaques","volume":"6","author":"Sui","year":"2021","journal-title":"JCI Insight"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41591-020-0868-6","type":"journal-article","article-title":"SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes","volume":"26","author":"Sungnak","year":"2020","journal-title":"Nature Medicine"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"12680","DOI":"10.1073\/pnas.1200024109","type":"journal-article","article-title":"Isotype modulates epitope specificity, affinity, and antiviral activities of anti-HIV-1 human broadly neutralizing 2F5 antibody","volume":"109","author":"Tudor","year":"2012","journal-title":"PNAS"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"5141","DOI":"10.1128\/JVI.75.11.5141-5150.2001","type":"journal-article","article-title":"Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection","volume":"75","author":"Tumpey","year":"2001","journal-title":"Journal of Virology"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.immuni.2020.05.002","type":"journal-article","article-title":"Immunology of COVID-19: current state of the science","volume":"52","author":"Vabret","year":"2020","journal-title":"Immunity"},{"key":"bib45","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abf1555","type":"journal-article","article-title":"Enhanced SARS-CoV-2 neutralization by dimeric IgA","volume":"13","author":"Wang","year":"2021","journal-title":"Science Translational Medicine"},{"key":"bib46","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-022-00451-7","type":"journal-article","article-title":"Intranasal administration of BReC-CoV-2 COVID-19 vaccine protects K18-hACE2 mice against lethal SARS-CoV-2 challenge","volume":"7","author":"Wong","year":"2022","journal-title":"NPJ Vaccines"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/path.1877","type":"journal-article","article-title":"The function of immunoglobulin A in immunity","volume":"208","author":"Woof","year":"2006","journal-title":"The Journal of Pathology"},{"key":"bib48","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6750-11-75","type":"journal-article","article-title":"Target-selective joint polymerase chain reaction: a robust and rapid method for high-throughput production of recombinant monoclonal antibodies from single cells","volume":"11","author":"Yoshioka","year":"2011","journal-title":"BMC Biotechnology"},{"key":"bib49","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2245921","type":"journal-article","article-title":"SARS-CoV-2 hijacks neutralizing dimeric IgA for nasal infection and injury in Syrian hamsters1","volume":"12","author":"Zhou","year":"2023","journal-title":"Emerging Microbes & Infections"},{"key":"bib50","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/S2213-2600(23)00349-1","type":"journal-article","article-title":"Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"11","author":"Zhu","year":"2023","journal-title":"The Lancet. Respiratory Medicine"}],"container-title":["eLife"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.elifesciences.org\/articles\/88387\/elife-88387-v1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cdn.elifesciences.org\/articles\/88387\/elife-88387-v1.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/elifesciences.org\/articles\/88387","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T09:37:49Z","timestamp":1787564269000},"score":1,"resource":{"primary":{"URL":"https:\/\/elifesciences.org\/articles\/88387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,8]]},"references-count":50,"alternative-id":["10.7554\/eLife.88387"],"URL":"https:\/\/doi.org\/10.7554\/elife.88387","archive":["CLOCKSS"],"relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.04.10.536311","asserted-by":"subject"}],"is-same-as":[{"id-type":"doi","id":"10.7554\/eLife.88387.3","asserted-by":"subject"}],"is-version-of":[{"id-type":"doi","id":"10.7554\/eLife.88387.1","asserted-by":"subject"},{"id-type":"doi","id":"10.7554\/eLife.88387.2","asserted-by":"subject"}]},"ISSN":["2050-084X"],"issn-type":[{"value":"2050-084X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,8]]},"assertion":[{"value":"single anonymised","name":"peer_review_transparency","label":"Peer review transparency","group":{"name":"peer_review_taxonomy"}},{"value":"other reviewer(s), editor","name":"peer_review_interaction","label":"Peer review interaction","group":{"name":"peer_review_taxonomy"}},{"value":"review summaries, review reports, author\/editor communication, reviewer identities reviewer opt in, editor identities","name":"peer_review_published","label":"Peer review published","group":{"name":"peer_review_taxonomy"}},{"value":"open (sign in with ORCID iD required)","name":"post_publication_commenting","label":"Post publication commenting","group":{"name":"post_publication_commenting"}}],"article-number":"RP88387"}}